Capobianco E. Overview of triple negative breast cancer prognostic signatures in the context of data science-driven clinico-genomics research. Ann Transl Med 2022;10:1300. [PMID: 36660729 DOI: 10.21037/atm-22-5477][Reference Citation Analysis]
2
Gou Q, Liu Z, Xie Y, Deng Y, Ma J, Li J, Zheng H. Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation. Front Pharmacol 2022;13:995555. [DOI: 10.3389/fphar.2022.995555][Reference Citation Analysis]
3
Araujo JM, De la Cruz-ku G, Cornejo M, Doimi F, Dyer R, Gomez HL, Pinto JA. Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes. Cancers 2022;14:4286. [DOI: 10.3390/cancers14174286][Reference Citation Analysis]